Morepen Laboratories Limited

NSE MOREPENLAB.NS

Morepen Laboratories Limited Gross Profit Margin for the year ending March 31, 2024: 36.33%

Morepen Laboratories Limited Gross Profit Margin is 36.33% for the year ending March 31, 2024, a 11.53% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Morepen Laboratories Limited Gross Profit Margin for the year ending March 31, 2023 was 32.58%, a 4.49% change year over year.
  • Morepen Laboratories Limited Gross Profit Margin for the year ending March 31, 2022 was 31.18%, a -5.70% change year over year.
  • Morepen Laboratories Limited Gross Profit Margin for the year ending March 31, 2021 was 33.06%, a -0.02% change year over year.
  • Morepen Laboratories Limited Gross Profit Margin for the year ending March 31, 2020 was 33.07%, a -2.83% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
NSE: MOREPENLAB.NS

Morepen Laboratories Limited

CEO Mr. Sushil Suri B.Sc., F.C.A., FCA
IPO Date Jan. 1, 1996
Location India
Headquarters 409, Antriksh Bhawan
Employees 2,152
Sector Health Care
Industries
Description

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India.

Similar companies

MANALIPETC.NS

Manali Petrochemicals Limited

USD 0.66

2.58%

LAURUSLABS.NS

Laurus Labs Limited

USD 6.56

1.75%

IOLCP.NS

IOL Chemicals and Pharmaceuticals Limited

USD 4.56

4.65%

HFCL.NS

HFCL Limited

USD 1.13

5.53%

MARKSANS.NS

Marksans Pharma Limited

USD 2.98

3.96%

StockViz Staff

January 15, 2025

Any question? Send us an email